Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy

E-ISSN： 1873-4286|14|11|1143-1150

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.11, 2008-04, pp. : 1143-1150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylenetetrahydrofolate reductase (MTHFR) variants and fluorouracil-based treatments in colorectal cancer

By Etienne-Grimaldi Marie-Christine Francoual Mireille Formento Jean-Louis Milano Géérard

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1561-1566

Future Medicine

Access to resources Recommend Favorite

14-3-3 zeta as novel molecular target for cancer therapy

By Matta Ajay Siu KW Michael Ralhan Ranju

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 515-523

Informa Healthcare

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphatase of regenerating liver: a novel target for cancer therapy

By Campbell Amanda M Zhang Zhong-Yin

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 555-569

Informa Healthcare

Access to resources Recommend Favorite

PDGF-D Signaling: A Novel Target in Cancer Therapy

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 38-41

Bentham Science Publishers

Access to resources Recommend Favorite